Topline data from FIBRONEER™-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change ...
The poultry medicine/pharmaceuticals market valued at US$ 4.73 billion in 2023, is forecasted to grow at a robust CAGR of 5.9%, reaching US$ ...
Among the usual suspects—sambar deer and curious macaques—an ancient, bizarre animal was captured on video for the first time in Cambodia: the large-antlered muntjac. An ancient animal with a ...
BI-765845 is under clinical development by Boehringer Ingelheim International and currently in Phase ... It offers an array of products including human diseases, animal health care products, and ...
If you want to easily collect your weight and other data in the Health app on iPhone and iPad, the thing to know is finding a scale that works with HealthKit and Apple Health. HealthKit is Apple ...
Boehringer Ingelheim’s trio of late-stage schizophrenia failures on Thursday came a day after the Department of Health and Human Services hit back on the pharma’s legal challenge to the IRA’s drug ...
HHS told the Second Circuit that Boehringer Ingelheim’s voluntary participation in Medicare negotiations “undermines” its legal challenge to the process.
13 Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in Research and Development, the company focuses on developing ...
Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a trio of late-stage trials. The phase 3 program missed both primary ...
13 Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in Research and Development, the company focuses on ...
Member of the Board of Managing Directors and Head of Human Pharma at Boehringer Ingelheim. “In the near future more can be expected. Our gratitude goes to the patients and clinical investigators ...
Here are some before and after pictures of the company's wordmark and logo. Need a break? Play the USA TODAY Daily Crossword Puzzle. Here's a look at how the new wordmark and logo will appear on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results